

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.02068980 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.34094867 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.27115156 |
| 4 | purine nucleobase biosynthetic process (GO:0009113) | 5.03877995 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.96623546 |
| 6 | nucleobase biosynthetic process (GO:0046112) | 4.96522710 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 4.85369716 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 4.85369716 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.85164100 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.77294819 |
| 11 | ribosome biogenesis (GO:0042254) | 4.54027317 |
| 12 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.38939481 |
| 13 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.33286190 |
| 14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.25115561 |
| 15 | DNA strand elongation (GO:0022616) | 4.16024706 |
| 16 | DNA replication initiation (GO:0006270) | 4.13426681 |
| 17 | protein retention in ER lumen (GO:0006621) | 4.11970977 |
| 18 | viral transcription (GO:0019083) | 4.07825488 |
| 19 | translational termination (GO:0006415) | 4.04805634 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.04520979 |
| 21 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.97279594 |
| 22 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.93974332 |
| 23 | spliceosomal snRNP assembly (GO:0000387) | 3.93927115 |
| 24 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.90963010 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 3.89634938 |
| 26 | translational elongation (GO:0006414) | 3.83793433 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.82799843 |
| 28 | barbed-end actin filament capping (GO:0051016) | 3.82701144 |
| 29 | pseudouridine synthesis (GO:0001522) | 3.77118833 |
| 30 | translational initiation (GO:0006413) | 3.76198416 |
| 31 | ribosomal small subunit biogenesis (GO:0042274) | 3.75551311 |
| 32 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.72180046 |
| 33 | protein localization to endosome (GO:0036010) | 3.69145658 |
| 34 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.67953041 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.66517706 |
| 36 | DNA replication checkpoint (GO:0000076) | 3.63364035 |
| 37 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.58264708 |
| 38 | pyrimidine nucleoside salvage (GO:0043097) | 3.57339906 |
| 39 | pyrimidine-containing compound salvage (GO:0008655) | 3.57339906 |
| 40 | rRNA processing (GO:0006364) | 3.54944693 |
| 41 | mitotic metaphase plate congression (GO:0007080) | 3.53993491 |
| 42 | nuclear envelope reassembly (GO:0031468) | 3.52809180 |
| 43 | mitotic nuclear envelope reassembly (GO:0007084) | 3.52809180 |
| 44 | protein insertion into membrane (GO:0051205) | 3.52402035 |
| 45 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.50493661 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.50474181 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.50474181 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 3.50334813 |
| 49 | virion assembly (GO:0019068) | 3.50069517 |
| 50 | ribosome assembly (GO:0042255) | 3.47983215 |
| 51 | proline biosynthetic process (GO:0006561) | 3.47808378 |
| 52 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.47097776 |
| 53 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.45839832 |
| 54 | termination of RNA polymerase III transcription (GO:0006386) | 3.45839832 |
| 55 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.44933067 |
| 56 | rRNA metabolic process (GO:0016072) | 3.44555883 |
| 57 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.44071763 |
| 58 | telomere maintenance via recombination (GO:0000722) | 3.43805973 |
| 59 | proteasome assembly (GO:0043248) | 3.41505459 |
| 60 | pentose metabolic process (GO:0019321) | 3.40848258 |
| 61 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.39034203 |
| 62 | DNA unwinding involved in DNA replication (GO:0006268) | 3.38308711 |
| 63 | IMP biosynthetic process (GO:0006188) | 3.35717861 |
| 64 | cellular component biogenesis (GO:0044085) | 3.34717284 |
| 65 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.34293195 |
| 66 | cotranslational protein targeting to membrane (GO:0006613) | 3.30891412 |
| 67 | pentose-phosphate shunt (GO:0006098) | 3.30747821 |
| 68 | protein targeting to ER (GO:0045047) | 3.29469348 |
| 69 | protein localization to kinetochore (GO:0034501) | 3.29123509 |
| 70 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.28763757 |
| 71 | histone arginine methylation (GO:0034969) | 3.27525355 |
| 72 | rRNA modification (GO:0000154) | 3.26056921 |
| 73 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.25734061 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.24202465 |
| 75 | pinocytosis (GO:0006907) | 3.23985509 |
| 76 | viral life cycle (GO:0019058) | 3.23340909 |
| 77 | viral protein processing (GO:0019082) | 3.21046671 |
| 78 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.19825592 |
| 79 | cellular protein complex disassembly (GO:0043624) | 3.19723180 |
| 80 | negative regulation of RNA splicing (GO:0033119) | 3.16261301 |
| 81 | purine-containing compound salvage (GO:0043101) | 3.14245776 |
| 82 | translation (GO:0006412) | 3.13826610 |
| 83 | regulation of early endosome to late endosome transport (GO:2000641) | 3.13669182 |
| 84 | positive regulation of ligase activity (GO:0051351) | 3.12802591 |
| 85 | peptidyl-arginine N-methylation (GO:0035246) | 3.12675319 |
| 86 | peptidyl-arginine methylation (GO:0018216) | 3.12675319 |
| 87 | protein localization to endoplasmic reticulum (GO:0070972) | 3.12199934 |
| 88 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.11051077 |
| 89 | telomere maintenance via telomere lengthening (GO:0010833) | 3.09067380 |
| 90 | tRNA methylation (GO:0030488) | 3.08635935 |
| 91 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.08313811 |
| 92 | mitochondrial fusion (GO:0008053) | 3.07562819 |
| 93 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.06287530 |
| 94 | folic acid metabolic process (GO:0046655) | 3.05857940 |
| 95 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05264750 |
| 96 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05264750 |
| 97 | mitotic recombination (GO:0006312) | 3.04696044 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.02870243 |
| 99 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.02870243 |
| 100 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.02870243 |
| 101 | maturation of 5.8S rRNA (GO:0000460) | 3.00303790 |
| 102 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.99635456 |
| 103 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.99635456 |
| 104 | cell cycle G1/S phase transition (GO:0044843) | 2.99266540 |
| 105 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.99266540 |
| 106 | protein complex disassembly (GO:0043241) | 2.99086706 |
| 107 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.98462148 |
| 108 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.97663579 |
| 109 | amyloid precursor protein catabolic process (GO:0042987) | 2.97319599 |
| 110 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.96541407 |
| 111 | negative regulation of cell size (GO:0045792) | 2.94728481 |
| 112 | spliceosomal complex assembly (GO:0000245) | 2.93989499 |
| 113 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.93534158 |
| 114 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.92291668 |
| 115 | UV protection (GO:0009650) | 2.90872884 |
| 116 | polyamine biosynthetic process (GO:0006596) | 2.90560163 |
| 117 | protein deneddylation (GO:0000338) | 2.89540143 |
| 118 | glucose catabolic process (GO:0006007) | 2.88883146 |
| 119 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88708950 |
| 120 | establishment of integrated proviral latency (GO:0075713) | 2.88528305 |
| 121 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.88119146 |
| 122 | regulation of ligase activity (GO:0051340) | 2.86938869 |
| 123 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.86646805 |
| 124 | modulation by virus of host process (GO:0019054) | 2.85830820 |
| 125 | macromolecular complex disassembly (GO:0032984) | 2.85545843 |
| 126 | metaphase plate congression (GO:0051310) | 2.85504949 |
| 127 | IMP metabolic process (GO:0046040) | 2.85367243 |
| 128 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.84941024 |
| 129 | intra-S DNA damage checkpoint (GO:0031573) | 2.84302241 |
| 130 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.83546224 |
| 131 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.83495350 |
| 132 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.83495350 |
| 133 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.83287969 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.83050293 |
| 135 | viral mRNA export from host cell nucleus (GO:0046784) | 2.82635243 |
| 136 | mitotic nuclear envelope disassembly (GO:0007077) | 2.82495294 |
| 137 | protein localization to chromosome, centromeric region (GO:0071459) | 2.82362050 |
| 138 | L-methionine biosynthetic process (GO:0071265) | 2.82083645 |
| 139 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81631472 |
| 140 | stress fiber assembly (GO:0043149) | 2.77345285 |
| 141 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.75079202 |
| 142 | modulation by symbiont of host cellular process (GO:0044068) | 2.75047305 |
| 143 | hyaluronan catabolic process (GO:0030214) | 2.73076884 |
| 144 | apoptotic process involved in morphogenesis (GO:0060561) | 2.73014892 |
| 145 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.72006092 |
| 146 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.71569525 |
| 147 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.70646421 |
| 148 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.69692888 |
| 149 | NADPH regeneration (GO:0006740) | 2.69056441 |
| 150 | lipopolysaccharide metabolic process (GO:0008653) | 2.62498678 |
| 151 | regulation of defense response to virus by virus (GO:0050690) | 2.60240605 |
| 152 | establishment of viral latency (GO:0019043) | 2.58964188 |
| 153 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.57976369 |
| 154 | amino sugar catabolic process (GO:0046348) | 2.57178837 |
| 155 | regulation of superoxide anion generation (GO:0032928) | 2.56727154 |
| 156 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.54573492 |
| 157 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.50825451 |
| 158 | mitotic chromosome condensation (GO:0007076) | 2.50703711 |
| 159 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.50498215 |
| 160 | positive regulation of protein sumoylation (GO:0033235) | 2.47593735 |
| 161 | nucleoside salvage (GO:0043174) | 2.46865256 |
| 162 | nucleotide salvage (GO:0043173) | 2.44595613 |
| 163 | cellular response to arsenic-containing substance (GO:0071243) | 2.42812257 |
| 164 | positive regulation of protein homooligomerization (GO:0032464) | 2.41876641 |
| 165 | adhesion of symbiont to host (GO:0044406) | 2.41722721 |
| 166 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.41292033 |
| 167 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.40867736 |
| 168 | metallo-sulfur cluster assembly (GO:0031163) | 2.39052922 |
| 169 | iron-sulfur cluster assembly (GO:0016226) | 2.39052922 |
| 170 | glucose 6-phosphate metabolic process (GO:0051156) | 2.37059280 |
| 171 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.35801033 |
| 172 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.34449380 |
| 173 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.34410293 |
| 174 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.34410293 |
| 175 | endothelial tube morphogenesis (GO:0061154) | 2.33851876 |
| 176 | morphogenesis of an endothelium (GO:0003159) | 2.33851876 |
| 177 | virion attachment to host cell (GO:0019062) | 2.31937263 |
| 178 | adhesion of symbiont to host cell (GO:0044650) | 2.31937263 |
| 179 | skin morphogenesis (GO:0043589) | 2.31374418 |
| 180 | regulation of translational termination (GO:0006449) | 2.31234264 |
| 181 | embryo implantation (GO:0007566) | 2.28695823 |
| 182 | modulation by virus of host morphology or physiology (GO:0019048) | 2.28340255 |
| 183 | basement membrane organization (GO:0071711) | 2.28138369 |
| 184 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.27722496 |
| 185 | protein targeting to mitochondrion (GO:0006626) | 2.27003994 |
| 186 | ncRNA 3-end processing (GO:0043628) | 2.25853542 |
| 187 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.24531234 |
| 188 | negative regulation of mitochondrion organization (GO:0010823) | 2.23411680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.45725250 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.31118287 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.25937839 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24813161 |
| 5 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.13203260 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.07236857 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.06194136 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.04409448 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.90712939 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.85545741 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.83762109 |
| 12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73693796 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.71783546 |
| 14 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.59388064 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.58682301 |
| 16 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.35171645 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33542144 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32373565 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.30504018 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.30474473 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.21680200 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21208687 |
| 23 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.19925796 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.19026306 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.15175889 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14654490 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.03888281 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03168903 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01793295 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.99430538 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98916885 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96996219 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94899796 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.94542350 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90263262 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90188066 |
| 37 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.89510218 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86146922 |
| 39 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.83744747 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83690856 |
| 41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.81817118 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81452183 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75614471 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75329840 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73525306 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.72746511 |
| 47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.70747889 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67313353 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64035666 |
| 50 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63324620 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62660212 |
| 52 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62009343 |
| 53 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60874253 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60457159 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57768718 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.56489871 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56156229 |
| 58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55979008 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54767744 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54367379 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50424933 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47887492 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46973762 |
| 64 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46867343 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42907497 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42880131 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42795856 |
| 68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40146955 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39594979 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38052327 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37783996 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37178395 |
| 73 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34985695 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34728706 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33600991 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33401077 |
| 77 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32827324 |
| 78 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32055720 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30118145 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29784514 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29004932 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.28897805 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28473857 |
| 84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27936399 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27213392 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.26361336 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25448753 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23550182 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21845120 |
| 90 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.21330293 |
| 91 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20199284 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19842757 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19710562 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18438066 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17518021 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.16989407 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16800538 |
| 98 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.16439959 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15856327 |
| 100 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15146074 |
| 101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15044074 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14604735 |
| 103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14483382 |
| 104 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13472325 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13233061 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12868410 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12852738 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12510688 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12442422 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12349621 |
| 111 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11159788 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10789929 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10459168 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10057984 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09481149 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09337430 |
| 117 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08662853 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07929381 |
| 119 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.06989571 |
| 120 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06966834 |
| 121 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06656008 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06550605 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06319673 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05611876 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04439612 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04179037 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04039787 |
| 128 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03754115 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03550667 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03549704 |
| 131 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03081404 |
| 132 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02754171 |
| 133 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02734627 |
| 134 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02372341 |
| 135 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01585692 |
| 136 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.00625941 |
| 137 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00546973 |
| 138 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96836369 |
| 139 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95176431 |
| 140 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93353979 |
| 141 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92711565 |
| 142 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92101616 |
| 143 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90587711 |
| 144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90562980 |
| 145 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89693483 |
| 146 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89646857 |
| 147 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88319317 |
| 148 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86228665 |
| 149 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86050896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.12609013 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.65962119 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.92652727 |
| 4 | MP0003077_abnormal_cell_cycle | 3.70698414 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.67160649 |
| 6 | MP0008260_abnormal_autophagy | 3.64697061 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.58082267 |
| 8 | MP0008007_abnormal_cellular_replicative | 3.48618065 |
| 9 | MP0010094_abnormal_chromosome_stability | 3.38718317 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 3.16407163 |
| 11 | MP0008058_abnormal_DNA_repair | 3.11898100 |
| 12 | MP0005451_abnormal_body_composition | 2.77491088 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.77395415 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.76564910 |
| 15 | MP0008057_abnormal_DNA_replication | 2.65068586 |
| 16 | MP0004858_abnormal_nervous_system | 2.48202347 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.47655455 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.41463826 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.40423643 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.33467938 |
| 21 | MP0001730_embryonic_growth_arrest | 2.31681976 |
| 22 | MP0003436_decreased_susceptibility_to | 2.08291181 |
| 23 | MP0000350_abnormal_cell_proliferation | 2.06643764 |
| 24 | MP0003123_paternal_imprinting | 2.05494849 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.05044261 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 2.04400039 |
| 27 | MP0001545_abnormal_hematopoietic_system | 2.04400039 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.97391561 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.96274471 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.94660527 |
| 31 | MP0003786_premature_aging | 1.92920485 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.90528008 |
| 33 | MP0000490_abnormal_crypts_of | 1.85525858 |
| 34 | MP0001542_abnormal_bone_strength | 1.71857337 |
| 35 | MP0004233_abnormal_muscle_weight | 1.71113944 |
| 36 | MP0001697_abnormal_embryo_size | 1.66319677 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.64873641 |
| 38 | MP0000313_abnormal_cell_death | 1.63467563 |
| 39 | MP0005380_embryogenesis_phenotype | 1.62129803 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.62129803 |
| 41 | MP0002080_prenatal_lethality | 1.61694521 |
| 42 | MP0003279_aneurysm | 1.59326915 |
| 43 | MP0003984_embryonic_growth_retardation | 1.53042300 |
| 44 | MP0006054_spinal_hemorrhage | 1.51387634 |
| 45 | MP0002132_abnormal_respiratory_system | 1.47969690 |
| 46 | MP0002088_abnormal_embryonic_growth/wei | 1.46655587 |
| 47 | MP0008995_early_reproductive_senescence | 1.45755466 |
| 48 | MP0004510_myositis | 1.43030852 |
| 49 | MP0003567_abnormal_fetal_cardiomyocyte | 1.42496999 |
| 50 | MP0003718_maternal_effect | 1.42436687 |
| 51 | MP0006082_CNS_inflammation | 1.41786348 |
| 52 | MP0005501_abnormal_skin_physiology | 1.41450707 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.41095986 |
| 54 | MP0005623_abnormal_meninges_morphology | 1.40108254 |
| 55 | MP0002085_abnormal_embryonic_tissue | 1.37515372 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.36820621 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.35447454 |
| 58 | MP0003303_peritoneal_inflammation | 1.33567461 |
| 59 | MP0003329_amyloid_beta_deposits | 1.26347602 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.23342997 |
| 61 | MP0003186_abnormal_redox_activity | 1.22807866 |
| 62 | MP0002084_abnormal_developmental_patter | 1.22359105 |
| 63 | MP0003091_abnormal_cell_migration | 1.20608182 |
| 64 | MP0004947_skin_inflammation | 1.20472732 |
| 65 | MP0002398_abnormal_bone_marrow | 1.20427841 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.20198169 |
| 67 | MP0002722_abnormal_immune_system | 1.19081144 |
| 68 | MP0000358_abnormal_cell_content/ | 1.18920736 |
| 69 | MP0004272_abnormal_basement_membrane | 1.16576356 |
| 70 | MP0002086_abnormal_extraembryonic_tissu | 1.15874752 |
| 71 | MP0000681_abnormal_thyroid_gland | 1.15843875 |
| 72 | MP0000685_abnormal_immune_system | 1.15465748 |
| 73 | MP0001293_anophthalmia | 1.13483571 |
| 74 | MP0003075_altered_response_to | 1.13207607 |
| 75 | MP0003315_abnormal_perineum_morphology | 1.12798939 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.11644664 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.11590826 |
| 78 | MP0003448_altered_tumor_morphology | 1.09977207 |
| 79 | MP0002060_abnormal_skin_morphology | 1.08948357 |
| 80 | MP0000751_myopathy | 1.08756337 |
| 81 | MP0002796_impaired_skin_barrier | 1.08693086 |
| 82 | MP0002210_abnormal_sex_determination | 1.08656425 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.08117623 |
| 84 | MP0008877_abnormal_DNA_methylation | 1.07517731 |
| 85 | MP0001348_abnormal_lacrimal_gland | 1.07333740 |
| 86 | MP0001958_emphysema | 1.06450067 |
| 87 | MP0004197_abnormal_fetal_growth/weight/ | 1.05825425 |
| 88 | MP0005025_abnormal_response_to | 1.04809329 |
| 89 | MP0002419_abnormal_innate_immunity | 1.03716371 |
| 90 | MP0000015_abnormal_ear_pigmentation | 1.02402160 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 1.02199733 |
| 92 | MP0000733_abnormal_muscle_development | 1.01983658 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 1.01765089 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.01367534 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.00842176 |
| 96 | MP0002429_abnormal_blood_cell | 0.99246163 |
| 97 | MP0001915_intracranial_hemorrhage | 0.98484396 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.98008940 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.95620275 |
| 100 | MP0001881_abnormal_mammary_gland | 0.95252457 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.94072430 |
| 102 | MP0001849_ear_inflammation | 0.93851759 |
| 103 | MP0002102_abnormal_ear_morphology | 0.93808861 |
| 104 | MP0001145_abnormal_male_reproductive | 0.92599289 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91386146 |
| 106 | MP0003119_abnormal_digestive_system | 0.90360332 |
| 107 | MP0000604_amyloidosis | 0.88768418 |
| 108 | MP0001119_abnormal_female_reproductive | 0.87801151 |
| 109 | MP0003121_genomic_imprinting | 0.87473532 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.87442115 |
| 111 | MP0003646_muscle_fatigue | 0.86405751 |
| 112 | MP0000759_abnormal_skeletal_muscle | 0.86277715 |
| 113 | MP0003122_maternal_imprinting | 0.86043853 |
| 114 | MP0005390_skeleton_phenotype | 0.85380084 |
| 115 | MP0005384_cellular_phenotype | 0.85286644 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.84714386 |
| 117 | MP0009379_abnormal_foot_pigmentation | 0.83778708 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.83570829 |
| 119 | MP0005508_abnormal_skeleton_morphology | 0.83418240 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.83309350 |
| 121 | MP0000747_muscle_weakness | 0.82138318 |
| 122 | MP0010307_abnormal_tumor_latency | 0.81842145 |
| 123 | MP0005171_absent_coat_pigmentation | 0.81551142 |
| 124 | MP0005621_abnormal_cell_physiology | 0.81333184 |
| 125 | MP0001853_heart_inflammation | 0.81033422 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.80410681 |
| 127 | MP0005330_cardiomyopathy | 0.79002678 |
| 128 | MP0000716_abnormal_immune_system | 0.78424529 |
| 129 | MP0002938_white_spotting | 0.78423012 |
| 130 | MP0005266_abnormal_metabolism | 0.78102971 |
| 131 | MP0000858_altered_metastatic_potential | 0.77868472 |
| 132 | MP0005023_abnormal_wound_healing | 0.77851397 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.77409737 |
| 134 | MP0002723_abnormal_immune_serum | 0.77377352 |
| 135 | MP0000653_abnormal_sex_gland | 0.76543727 |
| 136 | MP0000049_abnormal_middle_ear | 0.76248759 |
| 137 | MP0009931_abnormal_skin_appearance | 0.75379838 |
| 138 | MP0000767_abnormal_smooth_muscle | 0.75242477 |
| 139 | MP0002405_respiratory_system_inflammati | 0.75159509 |
| 140 | MP0001819_abnormal_immune_cell | 0.73442319 |
| 141 | MP0001929_abnormal_gametogenesis | 0.73107362 |
| 142 | MP0003806_abnormal_nucleotide_metabolis | 0.72976241 |
| 143 | MP0002420_abnormal_adaptive_immunity | 0.72404599 |
| 144 | MP0001661_extended_life_span | 0.72295032 |
| 145 | MP0000678_abnormal_parathyroid_gland | 0.72043523 |
| 146 | MP0001243_abnormal_dermal_layer | 0.71888141 |
| 147 | MP0000750_abnormal_muscle_regeneration | 0.71844871 |
| 148 | MP0010368_abnormal_lymphatic_system | 0.71708660 |
| 149 | MP0009053_abnormal_anal_canal | 0.71485294 |
| 150 | MP0002452_abnormal_antigen_presenting | 0.71275430 |
| 151 | MP0001727_abnormal_embryo_implantation | 0.71214196 |
| 152 | MP0002089_abnormal_postnatal_growth/wei | 0.68080398 |
| 153 | MP0002163_abnormal_gland_morphology | 0.67891098 |
| 154 | MP0001216_abnormal_epidermal_layer | 0.67746893 |
| 155 | MP0002127_abnormal_cardiovascular_syste | 0.67519286 |
| 156 | MP0009785_altered_susceptibility_to | 0.67459500 |
| 157 | MP0009278_abnormal_bone_marrow | 0.67354419 |
| 158 | MP0002249_abnormal_larynx_morphology | 0.66560826 |
| 159 | MP0009840_abnormal_foam_cell | 0.66389545 |
| 160 | MP0002751_abnormal_autonomic_nervous | 0.66363831 |
| 161 | MP0000343_altered_response_to | 0.65470520 |
| 162 | MP0005075_abnormal_melanosome_morpholog | 0.64994918 |
| 163 | MP0002160_abnormal_reproductive_system | 0.64730315 |
| 164 | MP0009697_abnormal_copulation | 0.63680349 |
| 165 | MP0004133_heterotaxia | 0.62030891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.82884037 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.71078732 |
| 3 | Degeneration of anterior horn cells (HP:0002398) | 4.29819137 |
| 4 | Abnormality of the anterior horn cell (HP:0006802) | 4.29819137 |
| 5 | Aplastic anemia (HP:0001915) | 4.01075851 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.97559822 |
| 7 | Reticulocytopenia (HP:0001896) | 3.93725894 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 3.80760990 |
| 9 | Microretrognathia (HP:0000308) | 3.78585832 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.78529624 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.78529624 |
| 12 | Oral leukoplakia (HP:0002745) | 3.76537948 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62556207 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62556207 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62556207 |
| 16 | Breast hypoplasia (HP:0003187) | 3.52303006 |
| 17 | Cerebral hypomyelination (HP:0006808) | 3.48817857 |
| 18 | Upper limb amyotrophy (HP:0009129) | 3.30788565 |
| 19 | Distal upper limb amyotrophy (HP:0007149) | 3.30788565 |
| 20 | Achilles tendon contracture (HP:0001771) | 3.28129827 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.20639846 |
| 22 | Thrombocytosis (HP:0001894) | 3.16859009 |
| 23 | Selective tooth agenesis (HP:0001592) | 3.16394817 |
| 24 | Hand muscle atrophy (HP:0009130) | 3.10379455 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 3.06238568 |
| 26 | Cholecystitis (HP:0001082) | 3.06238568 |
| 27 | Rough bone trabeculation (HP:0100670) | 3.03219216 |
| 28 | Hyperacusis (HP:0010780) | 3.02268094 |
| 29 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.96658414 |
| 30 | Patellar aplasia (HP:0006443) | 2.95053142 |
| 31 | Multiple enchondromatosis (HP:0005701) | 2.94049287 |
| 32 | Colon cancer (HP:0003003) | 2.93219116 |
| 33 | 11 pairs of ribs (HP:0000878) | 2.90497094 |
| 34 | Reduced antithrombin III activity (HP:0001976) | 2.89577781 |
| 35 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.88726647 |
| 36 | Trismus (HP:0000211) | 2.87384870 |
| 37 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.77039732 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.77039732 |
| 39 | Abnormal glycosylation (HP:0012345) | 2.77039732 |
| 40 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.77039732 |
| 41 | Hypertensive crisis (HP:0100735) | 2.72638888 |
| 42 | Abnormality of alanine metabolism (HP:0010916) | 2.71301385 |
| 43 | Hyperalaninemia (HP:0003348) | 2.71301385 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.71301385 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.70998505 |
| 46 | Carpal bone hypoplasia (HP:0001498) | 2.67464965 |
| 47 | Progressive muscle weakness (HP:0003323) | 2.66446932 |
| 48 | Generalized amyotrophy (HP:0003700) | 2.65917523 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.59868321 |
| 50 | Pallor (HP:0000980) | 2.57492784 |
| 51 | Axonal loss (HP:0003447) | 2.56457515 |
| 52 | Insomnia (HP:0100785) | 2.55068037 |
| 53 | Poor head control (HP:0002421) | 2.54994856 |
| 54 | Spinal rigidity (HP:0003306) | 2.51250773 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.50061841 |
| 56 | Long palpebral fissure (HP:0000637) | 2.48323048 |
| 57 | Macrocytic anemia (HP:0001972) | 2.46402190 |
| 58 | Increased serum lactate (HP:0002151) | 2.40609387 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.38938594 |
| 60 | Loss of speech (HP:0002371) | 2.36851703 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34139954 |
| 62 | Neoplasm of the pancreas (HP:0002894) | 2.33884695 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.33554610 |
| 64 | Muscle fiber atrophy (HP:0100295) | 2.31226745 |
| 65 | Slender long bone (HP:0003100) | 2.30935335 |
| 66 | Glossoptosis (HP:0000162) | 2.30488217 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.27085570 |
| 68 | Upper limb muscle weakness (HP:0003484) | 2.25876341 |
| 69 | Premature ovarian failure (HP:0008209) | 2.25163179 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 2.24177480 |
| 71 | Death in infancy (HP:0001522) | 2.23693649 |
| 72 | Ulnar bowing (HP:0003031) | 2.23014804 |
| 73 | Increased connective tissue (HP:0009025) | 2.21264264 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.21079625 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.19329023 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 2.18908970 |
| 77 | Abnormal number of incisors (HP:0011064) | 2.18729916 |
| 78 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.17320735 |
| 79 | Elbow flexion contracture (HP:0002987) | 2.15691291 |
| 80 | Postnatal microcephaly (HP:0005484) | 2.15580187 |
| 81 | Genu recurvatum (HP:0002816) | 2.15440785 |
| 82 | Secondary amenorrhea (HP:0000869) | 2.14660483 |
| 83 | Short nail (HP:0001799) | 2.14043397 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13904264 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13904264 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13904264 |
| 87 | Ankle contracture (HP:0006466) | 2.13391888 |
| 88 | Truncus arteriosus (HP:0001660) | 2.13268048 |
| 89 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.13262978 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.11205601 |
| 91 | Tongue fasciculations (HP:0001308) | 2.10257090 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 2.08877158 |
| 93 | Exertional dyspnea (HP:0002875) | 2.08657045 |
| 94 | Cervical subluxation (HP:0003308) | 2.08643225 |
| 95 | Premature graying of hair (HP:0002216) | 2.07816164 |
| 96 | CNS hypomyelination (HP:0003429) | 2.06594428 |
| 97 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.06206240 |
| 98 | Premature skin wrinkling (HP:0100678) | 2.06030543 |
| 99 | Unsteady gait (HP:0002317) | 2.05008495 |
| 100 | Absent thumb (HP:0009777) | 2.04493674 |
| 101 | Abnormal trabecular bone morphology (HP:0100671) | 2.04373587 |
| 102 | Myopathic facies (HP:0002058) | 2.04078454 |
| 103 | Stridor (HP:0010307) | 2.02105614 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.01969613 |
| 105 | Vertebral compression fractures (HP:0002953) | 1.99952165 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99296379 |
| 107 | Cleft eyelid (HP:0000625) | 1.99262525 |
| 108 | Muscle fibrillation (HP:0010546) | 1.98770776 |
| 109 | Abnormality of the motor neurons (HP:0002450) | 1.98303291 |
| 110 | Abnormal neuron morphology (HP:0012757) | 1.98303291 |
| 111 | Bulbar palsy (HP:0001283) | 1.98163597 |
| 112 | Fragile skin (HP:0001030) | 1.97932914 |
| 113 | Personality changes (HP:0000751) | 1.97725150 |
| 114 | Supranuclear gaze palsy (HP:0000605) | 1.97660588 |
| 115 | Male infertility (HP:0003251) | 1.97643038 |
| 116 | Acute lymphatic leukemia (HP:0006721) | 1.97592099 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 1.96271749 |
| 118 | Optic nerve coloboma (HP:0000588) | 1.94693116 |
| 119 | Abnormality of the tricuspid valve (HP:0001702) | 1.94059737 |
| 120 | Disproportionate tall stature (HP:0001519) | 1.93740830 |
| 121 | Reticulocytosis (HP:0001923) | 1.93597650 |
| 122 | Ragged-red muscle fibers (HP:0003200) | 1.92652395 |
| 123 | Nuclear cataract (HP:0100018) | 1.91151587 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 1.90844826 |
| 125 | Biconcave vertebral bodies (HP:0004586) | 1.89994710 |
| 126 | Hepatic necrosis (HP:0002605) | 1.89760749 |
| 127 | Abnormality of the umbilical cord (HP:0010881) | 1.88699674 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.88648898 |
| 129 | Blue sclerae (HP:0000592) | 1.88425809 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.86063320 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86063320 |
| 132 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.86029379 |
| 133 | Tracheoesophageal fistula (HP:0002575) | 1.85869935 |
| 134 | Hypokinesia (HP:0002375) | 1.85630128 |
| 135 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84855912 |
| 136 | IgM deficiency (HP:0002850) | 1.84548632 |
| 137 | Joint stiffness (HP:0001387) | 1.82886871 |
| 138 | Deformed tarsal bones (HP:0008119) | 1.82813385 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82287457 |
| 140 | Flattened epiphyses (HP:0003071) | 1.81609555 |
| 141 | Pancytopenia (HP:0001876) | 1.80925403 |
| 142 | Protrusio acetabuli (HP:0003179) | 1.80661151 |
| 143 | Testicular atrophy (HP:0000029) | 1.80440268 |
| 144 | Atresia of the external auditory canal (HP:0000413) | 1.78976309 |
| 145 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.78357762 |
| 146 | Broad distal phalanx of finger (HP:0009836) | 1.77808629 |
| 147 | Missing ribs (HP:0000921) | 1.77739852 |
| 148 | Calcaneovalgus deformity (HP:0001848) | 1.77141594 |
| 149 | Atrophic scars (HP:0001075) | 1.77091145 |
| 150 | Microvesicular hepatic steatosis (HP:0001414) | 1.75035144 |
| 151 | Mitral regurgitation (HP:0001653) | 1.74561457 |
| 152 | Cholelithiasis (HP:0001081) | 1.73620199 |
| 153 | Atelectasis (HP:0100750) | 1.73455886 |
| 154 | Nonimmune hydrops fetalis (HP:0001790) | 1.73430091 |
| 155 | Delusions (HP:0000746) | 1.73349446 |
| 156 | Increased serum ferritin (HP:0003281) | 1.72700990 |
| 157 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72307337 |
| 158 | Cellulitis (HP:0100658) | 1.71571270 |
| 159 | Bladder diverticulum (HP:0000015) | 1.71281681 |
| 160 | Abnormality of the ileum (HP:0001549) | 1.70381956 |
| 161 | Myelodysplasia (HP:0002863) | 1.70244797 |
| 162 | Spastic paraparesis (HP:0002313) | 1.69763111 |
| 163 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69548863 |
| 164 | Meckel diverticulum (HP:0002245) | 1.69511442 |
| 165 | Increased serum pyruvate (HP:0003542) | 1.68981282 |
| 166 | Abnormality of glycolysis (HP:0004366) | 1.68981282 |
| 167 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68767600 |
| 168 | Respiratory difficulties (HP:0002880) | 1.68651006 |
| 169 | Petechiae (HP:0000967) | 1.68556771 |
| 170 | Lactic acidosis (HP:0003128) | 1.68553008 |
| 171 | Diminished motivation (HP:0000745) | 1.67883516 |
| 172 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.67505365 |
| 173 | Single umbilical artery (HP:0001195) | 1.67505365 |
| 174 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.67505365 |
| 175 | Pendular nystagmus (HP:0012043) | 1.67063864 |
| 176 | Hypoplasia of the radius (HP:0002984) | 1.65700976 |
| 177 | Diaphragmatic weakness (HP:0009113) | 1.65620394 |
| 178 | Entropion (HP:0000621) | 1.64970006 |
| 179 | Slender build (HP:0001533) | 1.64960083 |
| 180 | Cerebral aneurysm (HP:0004944) | 1.64831169 |
| 181 | Neoplasm of head and neck (HP:0012288) | 1.64635725 |
| 182 | Esophageal neoplasm (HP:0100751) | 1.64635725 |
| 183 | Cellular immunodeficiency (HP:0005374) | 1.64140415 |
| 184 | Emotional lability (HP:0000712) | 1.63611834 |
| 185 | Bone marrow hypocellularity (HP:0005528) | 1.62081457 |
| 186 | Horseshoe kidney (HP:0000085) | 1.61368349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.14310197 |
| 2 | WEE1 | 4.13428196 |
| 3 | NME2 | 3.72972642 |
| 4 | IRAK3 | 3.08106297 |
| 5 | STK16 | 2.99755714 |
| 6 | SMG1 | 2.93668046 |
| 7 | PRPF4B | 2.85825975 |
| 8 | ACVR1B | 2.54597187 |
| 9 | NEK2 | 2.49211483 |
| 10 | EIF2AK1 | 2.40635527 |
| 11 | TESK2 | 2.31403967 |
| 12 | PKN2 | 2.11477833 |
| 13 | VRK2 | 2.06935513 |
| 14 | SRPK1 | 2.05831438 |
| 15 | ICK | 2.00808536 |
| 16 | CDC7 | 1.97735361 |
| 17 | DYRK3 | 1.93939794 |
| 18 | PASK | 1.91957669 |
| 19 | CCNB1 | 1.91644916 |
| 20 | PIM2 | 1.89526695 |
| 21 | NEK1 | 1.88365095 |
| 22 | SIK1 | 1.85282608 |
| 23 | KDR | 1.83652447 |
| 24 | TRIB3 | 1.74589694 |
| 25 | EPHA2 | 1.70356935 |
| 26 | RPS6KA4 | 1.67625112 |
| 27 | MAPKAPK3 | 1.66606345 |
| 28 | BRSK2 | 1.62817157 |
| 29 | MAP3K11 | 1.62378828 |
| 30 | FLT3 | 1.58702837 |
| 31 | SCYL2 | 1.58253515 |
| 32 | TSSK6 | 1.55541314 |
| 33 | ARAF | 1.55393398 |
| 34 | VRK1 | 1.54284842 |
| 35 | CDK7 | 1.48430670 |
| 36 | BRSK1 | 1.42399108 |
| 37 | PAK4 | 1.41719536 |
| 38 | PRKD3 | 1.41516684 |
| 39 | TLK1 | 1.36115101 |
| 40 | RPS6KB2 | 1.35972045 |
| 41 | EEF2K | 1.35708325 |
| 42 | TESK1 | 1.33980817 |
| 43 | PLK1 | 1.32812554 |
| 44 | LATS2 | 1.32343540 |
| 45 | TGFBR1 | 1.26873663 |
| 46 | ABL2 | 1.24916384 |
| 47 | BRAF | 1.24911257 |
| 48 | MAP3K12 | 1.16757934 |
| 49 | LMTK2 | 1.16218212 |
| 50 | BCKDK | 1.15911587 |
| 51 | MAP3K10 | 1.15588298 |
| 52 | AURKA | 1.14074604 |
| 53 | EIF2AK3 | 1.09877001 |
| 54 | CDK19 | 1.08916297 |
| 55 | KSR1 | 1.05451630 |
| 56 | EPHB2 | 1.03500743 |
| 57 | DYRK2 | 1.01787369 |
| 58 | KSR2 | 1.01540618 |
| 59 | AURKB | 1.01279021 |
| 60 | RAF1 | 1.00347112 |
| 61 | PRKD2 | 0.99571330 |
| 62 | TTN | 0.95191613 |
| 63 | KIT | 0.93304382 |
| 64 | ZAP70 | 0.92295280 |
| 65 | MAP4K1 | 0.91700439 |
| 66 | BMX | 0.91293692 |
| 67 | TBK1 | 0.90323426 |
| 68 | ERN1 | 0.87391933 |
| 69 | ATR | 0.87303483 |
| 70 | EPHB1 | 0.86617356 |
| 71 | MAP3K1 | 0.85631550 |
| 72 | LRRK2 | 0.84146279 |
| 73 | CHEK2 | 0.83283694 |
| 74 | ILK | 0.82851205 |
| 75 | PTK2 | 0.82355045 |
| 76 | MAP3K13 | 0.80222586 |
| 77 | LIMK1 | 0.79826530 |
| 78 | CAMKK2 | 0.78952645 |
| 79 | MUSK | 0.78194558 |
| 80 | DAPK1 | 0.77572055 |
| 81 | IRAK2 | 0.75221937 |
| 82 | CDK4 | 0.73449873 |
| 83 | DAPK3 | 0.73256909 |
| 84 | PAK1 | 0.72303319 |
| 85 | NME1 | 0.71276837 |
| 86 | PLK3 | 0.70246224 |
| 87 | MAP3K6 | 0.69823433 |
| 88 | TAOK2 | 0.68010837 |
| 89 | PBK | 0.66706263 |
| 90 | CDK8 | 0.65270598 |
| 91 | GRK6 | 0.65010050 |
| 92 | MAP3K8 | 0.64313404 |
| 93 | PLK4 | 0.64211238 |
| 94 | TAOK1 | 0.63095019 |
| 95 | PAK6 | 0.62472374 |
| 96 | SIK3 | 0.62436680 |
| 97 | CDK11A | 0.62023066 |
| 98 | WNK3 | 0.61641145 |
| 99 | PTK6 | 0.59204463 |
| 100 | DDR2 | 0.58865044 |
| 101 | MAP3K9 | 0.57067711 |
| 102 | CDK14 | 0.56680093 |
| 103 | RPS6KA2 | 0.56329930 |
| 104 | CHEK1 | 0.53661863 |
| 105 | PDPK1 | 0.53542780 |
| 106 | PDGFRA | 0.53325582 |
| 107 | CDK15 | 0.50990685 |
| 108 | NTRK1 | 0.50634346 |
| 109 | MAP2K3 | 0.50625393 |
| 110 | MKNK1 | 0.49498013 |
| 111 | MARK2 | 0.48656851 |
| 112 | PRKG2 | 0.48155208 |
| 113 | BLK | 0.48075933 |
| 114 | SIK2 | 0.47923904 |
| 115 | IRAK4 | 0.47033741 |
| 116 | CDK18 | 0.46980072 |
| 117 | TTK | 0.46124990 |
| 118 | PIM1 | 0.45982448 |
| 119 | BTK | 0.45229813 |
| 120 | CAMKK1 | 0.45208587 |
| 121 | CSNK2A1 | 0.44784497 |
| 122 | PRKCI | 0.44573295 |
| 123 | STK10 | 0.44383178 |
| 124 | JAK3 | 0.44292578 |
| 125 | RPS6KC1 | 0.43456697 |
| 126 | RPS6KL1 | 0.43456697 |
| 127 | MTOR | 0.42782017 |
| 128 | CSNK2A2 | 0.42482172 |
| 129 | PAK2 | 0.42145704 |
| 130 | CDC42BPA | 0.41359750 |
| 131 | NLK | 0.41253949 |
| 132 | MAP2K2 | 0.40846436 |
| 133 | CSF1R | 0.40492946 |
| 134 | STK4 | 0.39438946 |
| 135 | MAPKAPK2 | 0.39421553 |
| 136 | CDK2 | 0.38970190 |
| 137 | STK24 | 0.38125207 |
| 138 | CDK12 | 0.37140017 |
| 139 | TGFBR2 | 0.36375794 |
| 140 | ZAK | 0.36348912 |
| 141 | AKT2 | 0.33751497 |
| 142 | DYRK1B | 0.32659427 |
| 143 | MST1R | 0.31883587 |
| 144 | RIPK1 | 0.31513564 |
| 145 | MOS | 0.31416141 |
| 146 | MKNK2 | 0.30863228 |
| 147 | SYK | 0.30519339 |
| 148 | TYK2 | 0.29683881 |
| 149 | CAMK2G | 0.28382498 |
| 150 | MAP3K3 | 0.26601124 |
| 151 | MAPK11 | 0.24387767 |
| 152 | CSNK1G3 | 0.22087897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.61511675 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.94867872 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.94814428 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.79124321 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.51503655 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.30974822 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.28493306 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 3.11521524 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.90838843 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.88678427 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.80137073 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.59276456 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42621486 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.40369379 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.32609505 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 2.08010461 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94993907 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.90557984 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.86386575 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.85736805 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.83921536 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.70776072 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.68138663 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59093415 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.56021646 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40884438 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39962362 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38638694 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30921960 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30325200 |
| 31 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.27469817 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.24503142 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23402756 |
| 34 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21817428 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15422264 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15393593 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14323303 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14163767 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11894155 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10034683 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09558211 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08235903 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08090797 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.07451341 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 1.07399017 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05819994 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97544873 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97530205 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95115822 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93983309 |
| 51 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92686106 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91841623 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88521476 |
| 54 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87646055 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87633982 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84056639 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.84041669 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83822181 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83136343 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.82679213 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81602139 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80847181 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80551273 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79920307 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76960345 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76719423 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76349103 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.74379446 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73175208 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72742538 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70993892 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.69876772 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64274312 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63728159 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61496765 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60614810 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.60349915 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59574513 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59170399 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56004843 |
| 81 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54863485 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53978641 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.53134980 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.52988954 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52550739 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.51711955 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50469239 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46968138 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46801617 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46460048 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45799180 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45775226 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45148024 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45054347 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.44513110 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.44082583 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.43483945 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42935661 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42655954 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42034123 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41741891 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41564937 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41199127 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.39626413 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39495819 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39385245 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38692728 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38552022 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.36682322 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36024644 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35669279 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34728374 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.34578795 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33937200 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33497289 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33202881 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31702081 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31621255 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27522976 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26768308 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26752159 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.25867307 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25765159 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.25294125 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.24580111 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23272812 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22936345 |
| 128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.17889241 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17340540 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16713656 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.14704925 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.14464858 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.14341785 |
| 134 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.13322799 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.12835110 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12226225 |
| 137 | Pathways in cancer_Homo sapiens_hsa05200 | 0.12033267 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.11627365 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10342821 |

